LBBW Aktienanleihe FRE 28.03.2025/ DE000LB43H89 /
1/24/2025 9:23:42 AM | Chg.+0.01 | Bid1:02:21 PM | Ask1:02:21 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
100.91EUR | +0.01% | 100.90 Bid Size: 250,000 |
101.00 Ask Size: 250,000 |
FRESENIUS SE+CO.KGAA... | 25.00 - | 3/28/2025 | Call |
GlobeNewswire
4/24/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil